St. Helier, United Kingdom

Rebekah Elisabeth Key


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Jersey, GB (2014)
  • Cambridge, GB (2015)
  • St Helier, GB (2017)

Company Filing History:


Years Active: 2014-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Rebekah Elisabeth Key: Innovator in Therapeutic Compounds**

Introduction

Rebekah Elisabeth Key is an accomplished inventor based in St. Helier, GB, recognized for her significant contributions in the field of therapeutic compounds. With a total of three patents to her name, she has focused on innovative solutions aimed at combating serious health conditions, including certain types of cancer.

Latest Patents

Rebekah's latest inventions include two distinct patents for 3-aryl-5-substituted-isoquinolin-1-one compounds. These compounds are designed to target and inhibit poly(ADP-ribose) polymerase (PARP) and Wnt signaling pathways, which play vital roles in cell proliferation and tumor growth. The inventions encompass pharmaceutical compositions comprising these compounds, facilitating both in vitro and in vivo applications aimed at treating various disorders associated with PARP and Wnt signaling inhibition.

Career Highlights

Throughout her career, Rebekah has made significant strides in her field, working at renowned institutions such as the Institute of Cancer Research and St. George's Hospital Medical School. Her experience at these prestigious organizations has provided her with the platform to develop her innovative compounds and push the boundaries of therapeutic science.

Collaborations

Rebekah has collaborated with esteemed colleagues, including Trevor Robert Perrior and Alan Ashworth. These partnerships have enhanced her research endeavors, allowing her to combine expertise and insights to inspire impactful innovations in the medical field.

Conclusion

Rebekah Elisabeth Key stands out as a prominent figure in the landscape of therapeutic innovations. Her dedicated work in developing patented compounds underscores her commitment to advancing healthcare solutions that can potentially transform the treatment of proliferative conditions, particularly cancer. Her contributions not only reflect her innovative spirit but also her unwavering dedication to improving patient outcomes through scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…